Skip to content

AVANIR PHARMACEUTICALS, INC.

CIK 0000858803

← back to feed
Revenue (TTM)
$102.08M
+52.6% YoY FY Dec 2014
Net Income (TTM)
−$47.75M
+33.2% YoY FY Dec 2014
EPS Diluted (TTM)
—
FY Dec 2014
Gross Margin
28.1%
FY Dec 2014
Operating Margin
-43.2%
FY Dec 2014
Net Margin
-46.8%
FY Dec 2014
Free Cash Flow (TTM)
−$55.85M
FY Dec 2014
Cash
$271.87M
FY Dec 2014
Total Debt
$29.37M
FY Dec 2014
Shares Outstanding
193.76M sh
FY Dec 2014

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings